Linkage Assurance Plc has announced the appointment of Okanlawon Adelagun as its new Executive Director, Technical. The company’s Board of Directors at their recently-held Board meeting approved Adelagun’s appointment.
In a notification to the Nigerian Stock Exchange (NSE) and the general public, the company made known that Adelagun’s appointment will take effect from January 7, 2019.
Adelagun’s appointment is subject to the approval of the National Insurance Commission (NAICOM) and e-ratified by the Company’s shareholders.
Until his appointment, Adelagun was the Principal Consultant, Okadel Consultant, a consultancy firm that offers independent advisory services to corporate institutions on operations, underwriting, business and product development. He had formerly served as Executive Director (Business Development), Union Assurance Plc, and Managing Director, IGI Insurance (Ghana) Limited.
Adelagun is a Sociology graduate of University of Ibadan, Nigeria. He is an Associate Member of the Chartered Institute of Insurance of both Nigeria and London.
Adelagun will be bringing his ween of experience to rejuvenate the technical operations of the Company.
The company had released its financial results for the period ended September 30, 2018. Linkage Assurance Plc recorded a Gross Premium Income of N3.6 billion as against N3 billion in the corresponding period of 2017.
Profit before tax stood at N387 million in 2018 as against N2.8 billion in 2017. Profit after tax stood at N84 million in 2018 as against N2.8 billion in 2017.
About the firm
Linkage Assurance Plc was incorporated in Nigeria on March 26, 1991 as
a private limited liability company, and was licensed to cover and transact non-life insurance businesses on October 7, 1993. The company commenced its operations in January 1994.
In 2003, the company became a public limited liability company and Company’s shares, which were quoted on the NSE were first listed on November 18 of the same year.
The firm is one of the leading insurance service providers in Nigeria, with a reputation for prompt and accurate service delivery, efficiency and customer satisfaction.
Covid-19: WHO approves China’s Sinopharm vaccine
WHO has announced the approval of China’s Sinopharm vaccine for Covid-19 vaccination.
The World Health Organization (WHO) has announced the approval of China’s Sinopharm vaccine for Covid-19 vaccination. The vaccine is reported to have 79% efficacy against covid.
This was disclosed today in a report by Reuters. The vaccine would also be the second Chinese-made vaccine after Sinovac vaccine and would be the first developed outside Europe and North America to receive WHO accreditation.
“This expands the list of COVID-19 vaccines that COVAX can buy, and gives countries confidence to expedite their own regulatory approval, and to import and administer a vaccine,” WHO Director-General, Tedros Adhanom Ghebreyesus said.
The WHO added that the easy storage requirements make it highly suitable for low-resource settings.
“Its easy storage requirements make it highly suitable for low-resource settings,” a WHO statement said while also disclosing that the vaccine has been approved for people above the age of 18 to receive two shots.
“On the basis of all available evidence, WHO recommends the vaccine for adults 18 years and older, in a two-dose schedule with a spacing of three to four weeks,” the statement added.
The vaccine was created by Beijing Biological Products Institute, a subsidiary of Sinopharm subsidiary China National Biotec Group, with an efficacy of 79% for all age groups.
The WHO however, admitted that few older adults (over 60 years) were enrolled in clinical trials, so efficacy could not be estimated in this age group.
In case you missed it
The quest for vaccine efficiency got a major boost earlier this week as Nairametrics reported that the United States government announced that it supports the waiver of Intellectual Property Protections on Covid-19 vaccine development, in a bid to boost the fight against the pandemic, and says it will participate in the Okonjo-Iweala-led WTO negotiation to make it happen.
“Mama Taraba”, Former minister and senator, Aisha Al-Hassan is dead
Ex-Women Affairs minister, Aisha Jummai Al-Hassan, popularly known as Mama Taraba is dead
A former Minister for Women Affairs and ex-Governorship Candidate in Taraba State, Aisha Jummai Al-Hassan, popularly known as Mama Taraba is dead.
According to media reports she died in a hospital on Friday in Cairo, Egypt at the age of 61.
Al-Hassan, who was a former senator of the Federal Republic of Nigeria from Taraba North Senatorial District, was the All Progressive Congress (APC) Governorship Candidate for Taraba in the 2015 general elections.
She later contested for the same seat on the platform of the United Democratic Party in the 2019 general elections after resigning from APC and as a minister in the administration of President Muhammadu Buhari on July 27, 2018.
The former senator was born on the 16th of September, 1959 in Jalingo, Taraba State, to Alhaji Abubakar Ibrahim, Sarkin Ayukan Muri.
Aisha Jummai Al-Hassan attended Muhammed Nya Primary School, Jalingo and LEA Primary School, Tudun Wada, Kaduna before proceeding to Saint Faith College (now GGSS) Kawo Kaduna where she studied between January 1973 and June 1977.
Nairametrics | Company Earnings
Access our Live Feed portal for the latest company earnings as they drop.
- Okomu Oil proposes dividend worth N6.7 billion for shareholders.
- Ardova Plc confirms appointment of Oladeinde Nelson-Cole as secretary.
- Cadbury Nigeria Plc set to hold 56th Annual General Meeting (AGM) on June 16.
- FCMB Group Plc appoints Muibat Ijaiya as Director.
- Afromedia Plc reports a loss after tax of N27.3 million in Q1 2021.